Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval-Reference-Cited by-同舟云学术

Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval

Published:2004-11-05 Issue:2 Volume:67 Page:531-540
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Martínez Jordi,Vögler Oliver,Casas Jesús,Barceló Francisca,Alemany Regina,Prades Jesús,Nagy Tünde,Baamonde Carmela,Kasprzyk Philip G.,Terés Silvia,Saus Carlos,Escribá Pablo V.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference57 articles.

1. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization

2. The hypotensive drug 2-hydroxyoleic acid modifies the structural properties of model membranes

3. Cyclin-Dependent Kinase-2 Controls Oligodendrocyte Progenitor Cell Cycle Progression and Is Downregulated in Adult Oligodendrocyte Progenitors

4. Asymmetry and transposition rate of phosphatidylcholine in rat erythrocyte ghosts

5. Protein kinase C: a worthwhile target for anticancer drugs?

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olive Oil: A Seasoning and Something More;Tales of Discovery;2024

2. A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma;British Journal of Cancer;2023-07-24

3. Structural Basis of the Interaction of the G Proteins, Gαi1, Gβ1γ2 and Gαi1β1γ2, with Membrane Microdomains and Their Relationship to Cell Localization and Activity;Biomedicines;2023-02-14

4. The anti-tumor drug 2-hydroxyoleic acid regulates the oncogenic potassium channel Kv10.1;Beni-Suef University Journal of Basic and Applied Sciences;2023-02-03

5. Uncovering the Potential of Lipid Drugs: A Focus on Transient Membrane Microdomain-targeted Lipid Therapeutics;Mini-Reviews in Medicinal Chemistry;2022-10